Skip to main content

Navigation group

Type at least 3 characters
627 articles

Articles

Original Research

Published on 21 Nov 2024

A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

  • Ahmed Bilal Khalid
  • Christos Fountzilas
  • Heather N. Burney
  • Hirva Mamdani
  • Bryan P. Schneider
  • Christopher Fausel
  • Susan M. Perkins
  • Shadia Jalal
Frontiers in Oncology
doi 10.3389/fonc.2024.1435056
  • 126 views